Oxidative stress is a contributing factor that leads to the vascular complications of diabetes mellitus. Diabetic peripheral neuropathy (DPN) is one of the microvascular complications with rising concern as the disease progresses despite strict glucose control and monitoring. Thus, there is an ongoing need for an early intervention that is effective in halting or slowing the progression of DPN where antioxidants have been proposed as potential therapeutic agents. This systematic review aims to evaluate the existing evidence on the antioxidant effect in DPN and provide insight on the role of antioxidants in the progression of DPN in a rat model. A comprehensive literature search was conducted on Web of Science, EBSCOhost, and Scopus to identify the effects and role of antioxidants in DPN. Data extraction was performed and SYRCLE's risk of bias (RoB) tool was used for risk assessment. This systematic review was written following the PRISMA 2020 statements. From the literature search, 1268 articles were screened, and a total of 101 full-text articles were further screened before 33 were analyzed. These findings collectively suggest that antioxidants can play a crucial role in managing and potentially reversing the effects of diabetic neuropathy by targeting oxidative stress and improving nerve function.

1. Al-Rejaie, S. S., Aleisa, A. M., Abuohashish, H. M., Parmar, M. Y., Ola, M. S., Al-Hosaini, A. A., & Ahmed, M. M. (2015). Naringenin neutralises oxidative stress and nerve growth factor discrepancy in experimental diabetic neuropathy. Neurological Research, 37(10), 924–933. https://doi.org/10.1179/1743132815Y.0000000078
2. AlSharari, S. D., Al-Rejaie, S. S., Abuohashish, H. M., Aleisa, A. M., Parmar, M. Y., & Ahmed, M. M. (2014). Ameliorative potential of morin in streptozotocin-induced neuropathic pain in rats. Tropical Journal of Pharmaceutical Research, 13(9), 1429–1436. https://doi.org/10.4314/tjpr.v13i9.8
3. Adki, K. M., & Kulkarni, Y. A. (2021). Neuroprotective effect of paeonol in streptozotocin-induced diabetes in rats. Life Sciences, 271, Article 119202. https://doi.org/10.1016/j.lfs.2021.119202
4. Agnes, J. P., dos Santos, V. W., das Neves, R. N., Gonçalves, R. M., Delgobo, M., Girardi, C. S., Lückemeyer, D. D., Ferreira, M. d. A., Macedo-Júnior, S. J., Lopes, S. C., & et al. (2021). Antioxidants improve oxaliplatin-induced peripheral neuropathy in tumor-bearing mice model: Role of spinal cord oxidative stress and inflammation. The Journal of Pain, 22(8), 996–1013. https://doi.org/10.1016/j.jpain.2021.03.140
5. Archana, J., Annapurna, A., & Devayani, P. (2022). Neuroprotective role of Tinospora cordifolia extract in streptozotocin induced neuropathic pain. Brazilian Journal of Pharmaceutical Sciences, 58, Article e18501. https://doi.org/10.1590/s2175-97902022e18501
6. Balaha, M., Kandeel, S., & Kabel, A. (2018). Phloretin either alone or in combination with duloxetine alleviates the STZ-induced diabetic neuropathy in rats. Biomedicine & Pharmacotherapy, 101, 821–832. https://doi.org/10.1016/j.biopha.2018.03.002
7. Baluchnejadmojarad, T., Roghani, M., & Khastehkhodaie, Z. (2010). Chronic treatment of silymarin improves hyperalgesia and motor nerve conduction velocity in diabetic neuropathic rat. Phytotherapy Research, 24(8), 1120–1125. https://doi.org/10.1002/ptr.3045
8. Bana, S., Kumar, N., Sartaj, A., Alhalmi, A., Qurtam, A. A., Nasr, F. A., Al-Zharani, M., Singh, N., Gaur, P., Mishra, R., & et al. (2023). Rubia cordifolia L. attenuates diabetic neuropathy by inhibiting apoptosis and oxidative stress in rats. Pharmaceuticals, 16(11), Article 1586. https://doi.org/10.3390/ph16111586
9. Bandeira, S. D. M., Guedes, G. D. S., Da Fonseca, L. J. S., Pires, A. S., Gelain, D. P., Moreira, J. C. F., Rabelo, L. A., Vasconcelos, S. M. L., & Goulart, M. O. F. (2012). Characterization of blood oxidative stress in type 2 diabetes mellitus patients: Increase in lipid peroxidation and SOD activity. Oxidative Medicine and Cellular Longevity, 2012, Article 819310. https://doi.org/10.1155/2012/819310
10. Barrière, D. A., Dupuis, A., & Courteix, C. (2012). Rodent models of painful diabetic neuropathy: What can we learn from them? Journal of Diabetes & Metabolism, 2012, Article 5.
11. Bin-Jaliah, I., El-Attar, S., Khaleel, E. F., El-Sayed, L. A., & Haidara, M. A. (2013). Remedial effects of vitamin E and L-arginine on peripheral neuropathy in streptozotocin-induced diabetic rats. American Journal of Pharmacology and Toxicology, 9(1), 13–23. https://doi.org/10.3844/ajptsp.2014.13.23
12. Campos, C. (2012). Chronic hyperglycemia and glucose toxicity: Pathology and clinical sequelae. Postgraduate Medicine, 124(6), 90–97. https://doi.org/10.3810/pgm.2012.11.2615
13. Carmichael, J., Fadavi, H., Ishibashi, F., Shore, A.C., & Tavakoli, M. (2021). Advances in screening, early diagnosis and accurate staging of diabetic neuropathy. Frontiers in Endocrinology, 12, Article 671257. https://doi.org/10.3389/fendo.2021.671257
14. Chen, X., Graham, J., Dabbah, M. A., Petropoulos, I. N., Ponirakis, G., Asghar, O., Alam, U., Marshall, A. G., Fadavi, H., Ferdousi, M., & et al. (2015). Small nerve fiber quantification in the diagnosis of diabetic sensorimotor polyneuropathy: Comparing corneal confocal microscopy with intraepidermal nerve fiber density. Diabetes Care, 38(6), 1138–1144. https://doi.org/10.2337/dc14-2422
15. Comelli, F., Bettoni, I., Colleoni, M., Giagnoni, G., & Costa, B. (2009). Beneficial effects of a Cannabis sativa extract treatment on diabetes-induced neuropathy and oxidative stress. Phytotherapy Research, 23(12), 1678–1684. https://doi.org/10.1002/ptr.2806
16. Cui, X. P., Li, B. Y., Gao, H. Q., Wei, N., Wang, W. L., & Lu, M. (2008). Effects of grape seed proanthocyanidin extracts on peripheral nerves in streptozocin-induced diabetic rats. Journal of Nutritional Science and Vitaminology, 54(4), 321–328. https://doi.org/10.3177/jnsv.54.321
17. DaSilva, J. K., & Arezzo, J. C. (2020). Use of nerve conduction assessments to evaluate drug-induced peripheral neuropathy in nonclinical species—A brief review. Toxicologic Pathology, 48(1), 71–77. https://doi.org/10.1177/0192623319853900
18. David, K., Tracey, W., & Bero, J. (2013). Instruments for assessing risk of bias and other methodological criteria of published animal studies: A systematic review. Environmental Health Perspectives, 121(9), 985–992. https://doi.org/10.1289/ehp.1206389
19. Devigili, G., Rinaldo, S., Lombardi, R., Cazzato, D., Marchi, M., Salvi, E., Eleopra, R., & Lauria, G. (2019). Diagnostic criteria for small fibre neuropathy in clinical practice and research. Brain, 142(12), 3728–3736. https://doi.org/10.1093/brain/awz333
20. Dewanjee, S., Das, S., Das, A. K., Bhattacharjee, N., Dihingia, A., Dua, T. K., Kalita, J., & Manna, P. (2018). Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets. European Journal of Pharmacology, 833, 472–523. https://doi.org/10.1016/j.ejphar.2018.06.034
21. Dhaliwal, J., Dhaliwal, N., Akhtar, A., Kuhad, A., & Chopra, K. (2020). Beneficial effects of ferulic acid alone and in combination with insulin in streptozotocin induced diabetic neuropathy in Sprague Dawley rats. Life Sciences, 255, Article 117856. https://doi.org/10.1016/j.lfs.2020.117856
22. Dworzański, J., Strycharz-Dudziak, M., Kliszczewska, E., Kiełczykowska, M., Dworzańska, A., Drop, B., & Polz-Dacewicz, M. (2020). Glutathione peroxidase (GPx) and superoxide dismutase (SOD) activity in patients with diabetes mellitus type 2 infected with Epstein-Barr virus. PLoS ONE, 15(3), Article e0230374. https://doi.org/10.1371/journal.pone.0230374
23. El-Baz, F. K., Salama, A., Salama, R. A. A., & Gabr, M. (2020). Dunaliella salina attenuates diabetic neuropathy induced by STZ in rats: Involvement of thioredoxin. BioMed Research International, 2020, Article 1295492. https://doi.org/10.1155/2020/1295492
24. Fink, B., Coppey, L., Davidson, E., Shevalye, H., Obrosov, A., Chheda, P. R., Kerns, R., Sivitz, W., & Yorek, M. (2020). Effect of mitoquinone (Mito-Q) on neuropathic endpoints in an obese and type 2 diabetic rat model. Free Radical Research, 54(5), 311–318. https://doi.org/10.1080/10715762.2020.1764601
25. Furman, B. L. (2021). Streptozotocin-induced diabetic models in mice and rats. Current Protocols, 1(4), Article e78. https://doi.org/10.1002/cpz1.78
26. Gheibi, S., Kashfi, K., & Ghasemi, A. (2017). A practical guide for induction of type-2 diabetes in rat: Incorporating a high-fat diet and streptozotocin. Biomedicine & Pharmacotherapy, 95, 605–613. https://doi.org/10.1016/j.biopha.2017.08.106
27. Gugliucci, A. (2017). Formation of fructose-mediated advanced glycation end products and their roles in metabolic and inflammatory diseases. Advances in Nutrition, 8(1), 54–62. https://doi.org/10.3945/an.116.013912
28. Höke, A. (2012). Animal models of peripheral neuropathies. Neurotherapeutics, 9(2), 262–269. https://doi.org/10.1007/s13311-012-0116-y
29. Hooijmans, C. R., Rovers, M. M., de Vries, R. B. M., Leenaars, M., Ritskes-Hoitinga, M., & Langendam, M. W. (2014). SYRCLE’s risk of bias tool for animal studies. BMC Medical Research Methodology, 14, Article 43. https://doi.org/10.1186/1471-2288-14-43
30. Huseyinoglu, N., Ozaydin, I., Huseyinoglu, U., Yayla, S., & Aksoy, O. (2013). Minimally invasive motor nerve conduction study of the rat sciatic and tail nerves. Kafkas Universitesi Veteriner Fakultesi Dergisi, 19(6), 943–948. https://doi.org/10.9775/kvfd.2013.9295
31. Kafle, D. R. (2022). Effect of persistent hyperglycemia and lipid profile and its role in glycation and oxidative stress in chronic type 2 diabetes mellitus subjects. Nepal Medical Journal, 5(1), 20–24. https://doi.org/10.3126/nmj.v5i1.44299
32. Kamdi, S. P., Raval, A., & Nakhate, K. T. (2021). Effect of apple peel extract on diabetes-induced peripheral neuropathy and wound injury. Journal of Diabetes & Metabolic Disorders, 20(1), 119–130. https://doi.org/10.1007/s40200-020-00720-3
33. Kandhare, A. D., Raygude, K. S., Ghosh, P., Ghule, A. E., & Bodhankar, S. L. (2012). Neuroprotective effect of naringin by modulation of endogenous biomarkers in streptozotocin induced painful diabetic neuropathy. Fitoterapia, 83(4), 650–659. https://doi.org/10.1016/j.fitote.2012.01.004
34. Kern, T. S., Miller, C. M., Tang, J., Du, Y. L., Ball, S. L., & Berti-Matera, L. (2010). Comparison of three strains of diabetic rats with respect to the rate at which retinopathy and tactile allodynia develop. Molecular Vision, 16, 1629–1639.
35. Kiasalari, Z., Rahmani, T., Mahmoudi, N., Baluchnejadmojarad, T., & Roghani, M. (2017). Diosgenin ameliorates development of neuropathic pain in diabetic rats: Involvement of oxidative stress and inflammation. Biomedicine & Pharmacotherapy, 86, 654–661. https://doi.org/10.1016/j.biopha.2016.12.071
36. Kim, S. O., & Kim, H. J. (2013). Berberine ameliorates cold and mechanical allodynia in a rat model of diabetic neuropathy. Journal of Medicinal Food, 16(6), 511–517. https://doi.org/10.1089/jmf.2012.2578
37. Kishore, L., Kaur, N., & Singh, R. (2017). Bacosine isolated from aerial parts of Bacopa monnieri improves the neuronal dysfunction in streptozotocin-induced diabetic neuropathy. Journal of Functional Foods, 34, 237–247. https://doi.org/10.1016/j.jff.2017.04.032
38. Koneri, R. B., Samaddar, S., Simi, S., & Rao, S. T. (2014). Neuroprotective effect of a triterpenoid saponin isolated from Momordica cymbalaria Fenzl in diabetic peripheral neuropathy. Indian Journal of Pharmacology, 46(1), 76–81. https://doi.org/10.4103/0253-7613.125178
39. Kuhad, A., & Chopra, K. (2009). Tocotrienol attenuates oxidative-nitrosative stress and inflammatory cascade in experimental model of diabetic neuropathy. Neuropharmacology, 57(4), 456–462. https://doi.org/10.1016/j.neuropharm.2009.06.042
40. Kumar, A., Kaundal, R. K., Iyer, S., & Sharma, S. S. (2007). Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy. Life Sciences, 80(13), 1236–1244. https://doi.org/10.1016/j.lfs.2006.12.019
41. Lauria, G., Hsieh, S. T., Johansson, O., Kennedy, W. R., Leger, J. M., Mellgren, S. I., Nolano, M., Merkies, I. S., Polydefkis, M., Smith, A. G., & et al. (2010). European Federation of Neurological Societies/Peripheral Nerve Society guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. European Journal of Neurology, 17(7), 903-e49. https://doi.org/10.1111/j.1468-1331.2010.03023.x
42. Lauria, G., Lombardi, R., Borgna, M., Penza, P., Bianchi, R., Savino, C., Canta, A., Nicolini, G., Marmiroli, P., & Cavaletti, G. (2005). Intraepidermal nerve fiber density in rat foot pad: Neuropathologic–neurophysiologic correlation. Journal of the Peripheral Nervous System, 10(2), 202–208. https://doi.org/10.1111/j.1085-9489.2005.0010207.x
43. Lee, K. A., Lee, N. Y., Park, T. S., & Jin, H. Y. (2018). Comparison of peripheral nerve protection between insulin-based glucose control and alpha lipoic acid (ALA) in the streptozotocin (STZ)-induced diabetic rat. Endocrine, 61(1), 58–67. https://doi.org/10.1007/s12020-018-1582-y
44. Liao, C., Yang, M., Liu, P., Zhong, W., & Zhang, W. (2018). Stable rat model of mechanical allodynia in diabetic peripheral neuropathy: The role of nerve compression. Journal of Reconstructive Microsurgery, 34(4), 264–269. https://doi.org/10.1055/s-0037-1615814
45. Liu, F., Ma, F., Kong, G., Wu, K., Deng, Z., & Wang, H. (2014). Zinc supplementation alleviates diabetic peripheral neuropathy by inhibiting oxidative stress and upregulating metallothionein in peripheral nerves of diabetic rats. Biological Trace Element Research, 158(2), 211–218. https://doi.org/10.1007/s12011-014-9923-y
46. Liu, Y., Wang, L., Li, X., Lv, C., Feng, D., & Luo, Z. (2010). Tanshinone IIA improves impaired nerve functions in experimental diabetic rats. Biochemical and Biophysical Research Communications, 399(1), 49–54. https://doi.org/10.1016/j.bbrc.2010.07.034
47. Ma, B., Xu, J. K., Wu, W. J., Liu, H., Kou, C. K., Liu, N., & Zhao, L. (2017). Survey of basic medical researchers on the awareness of animal experimental designs and reporting standards in China. PLoS ONE, 12(4), Article e0174530. https://doi.org/10.1371/journal.pone.0174530
48. Määttä, L. L., Andersen, S. T., Parkner, T., Hviid, C. V. B., Bjerg, L., Kural, M. A., Charles, M., Søndergaard, E., Kuhle, J., Tankisi, H., & et al. (2024). Longitudinal change in serum neurofilament light chain in type 2 diabetes and early diabetic polyneuropathy: ADDITION-Denmark. Diabetes Care, 47(6), 986–994. https://doi.org/10.2337/dc23-2280
49. Muramatsu, K. (2020). Diabetes mellitus-related dysfunction of the motor system. International Journal of Molecular Sciences, 21(20), Article 7485. https://doi.org/10.3390/ijms21207485
50. Najafi, R., Hosseini, A., Ghaznavi, H., Mehrzadi, S., & Sharifi, A. M. (2017). Neuroprotective effect of cerium oxide nanoparticles in a rat model of experimental diabetic neuropathy. Brain Research Bulletin, 131, 117–122. https://doi.org/10.1016/j.brainresbull.2017.03.013
51. O’Brien, P. D., Sakowski, S. A., & Feldman, E. L. (2014). Mouse models of diabetic neuropathy. ILAR Journal, 54(3), 259–272. https://doi.org/10.1093/ilar/ilt052
52. Pál, E., Fülöp, K., Tóth, P., Deli, G., Pfund, Z., Janszky, J., & Komoly, S. (2020). Small fiber neuropathy: Clinicopathological correlations. Behavioral Neurology, 2020, Article 8796519. https://doi.org/10.1155/2020/8796519
53. Percie du Sert, N., Hurst, V., Ahluwalia, A., Alam, S., Avey, M. T., Baker, M., Browne, W. J., Clark, A., Cuthill, I. C., Dirnagl, U., & et al. (2020). The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. Journal of Cerebral Blood Flow & Metabolism, 40(9), 1769–1777. https://doi.org/10.1177/0271678X20943869
54. Ranjithkumar, R., Prathab Balaji, S., Balaji, B., Ramesh, R. V., & Ramanathan, M. (2013). Standardized aqueous Tribulus terristris (Nerunjil) extract attenuates hyperalgesia in experimentally induced diabetic neuropathic pain model: Role of oxidative stress and inflammatory mediators. Phytotherapy Research, 27(11), 1646–1657. https://doi.org/10.1002/ptr.4911
55. Rashedinia, M., Alimohammadi, M., Shalfroushan, N., Khoshnoud, M. J., Mansourian, M., Azarpira, N., & Sabahi, Z. (2020). Neuroprotective effect of syringic acid by modulation of oxidative stress and mitochondrial mass in diabetic rats. BioMed Research International, 2020, Article 8297984. https://doi.org/10.1155/2020/8297984
56. Remelli, F., Ceresini, M. G., Trevisan, C., Noale, M., & Volpato, S. (2022). Prevalence and impact of polypharmacy in older patients with type 2 diabetes. Aging Clinical and Experimental Research, 34(9), 1969–1983. https://doi.org/10.1007/s40520-022-02165-1
57. Sánchez-Alcázar, J., Villalón-García, I., Povea-Cabello, S., Álvarez-Córdoba, M., Talaverón-Rey, M., Suárez-Rivero, J., Suárez-Carrillo, A., Munuera-Cabeza, M., Reche-López, D., Cilleros-Holgado, P., & et al. (2023). Vicious cycle of lipid peroxidation and iron accumulation in neurodegeneration. Neural Regeneration Research, 18(6), 1196–1202. https://doi.org/10.4103/1673-5374.358614
58. Shabalala, S. C., Johnson, R., Basson, A. K., Ziqubu, K., Hlengwa, N., Mthembu, S. X. H., Mabhida, S. E., Mazibuko-Mbeje, S. E., Hanser, S., Cirilli, I., & et al. (2022). Detrimental effects of lipid peroxidation in type 2 diabetes: Exploring the neutralizing influence of antioxidants. Antioxidants, 11(11), Article 2071. https://doi.org/10.3390/antiox11112071
59. Shaikh, A. S., & Somani, R. S. (2010). Animal models and biomarkers of neuropathy in diabetic rodents. Indian Journal of Pharmacology, 42(3), 129–134. https://doi.org/10.4103/0253-7613.65147
60. Sharma, S. S., & Sayyed, S. G. (2006). Effects of trolox on nerve dysfunction, thermal hyperalgesia and oxidative stress in experimental diabetic neuropathy. Clinical and Experimental Pharmacology and Physiology, 33(11), 1022–1028. https://doi.org/10.1111/j.1440-1681.2006.04481.x
61. Shillo, P., Sloan, G., Greig, M., Hunt, L., Selvarajah, D., Elliott, J., Gandhi, R., Wilkinson, I. D., & Tesfaye, S. (2019). Painful and painless diabetic neuropathies: What is the difference? Current Diabetes Reports, 19(6), Article 32. https://doi.org/10.1007/s11892-019-1150-5
62. Singh, R., Kishore, L., & Kaur, N. (2014). Diabetic peripheral neuropathy: Current perspective and future directions. Pharmacological Research, 80, 21–35. https://doi.org/10.1016/j.phrs.2013.12.005
63. Starobova, H., & Vetter, I. (2017). Pathophysiology of chemotherapy-induced peripheral neuropathy. Frontiers in Molecular Neuroscience, 10, Article 174. https://doi.org/10.3389/fnmol.2017.00174
64. Suryavanshi, S. V., & Kulkarni, Y. A. (2020). Escin alleviates peripheral neuropathy in streptozotocin induced diabetes in rats. Life Sciences, 254, Article 117777. https://doi.org/10.1016/j.lfs.2020.117777
65. Tavee, J. O. (2018). Office approach to small fiber neuropathy. Cleveland Clinic Journal of Medicine, 85(10), 801–812. https://doi.org/10.3949/ccjm.85a.17112
66. Tian, R., Yang, W., Xue, Q., Gao, L., Huo, J., Ren, D., & Chen, X. (2016). Rutin ameliorates diabetic neuropathy by lowering plasma glucose and decreasing oxidative stress via Nrf2 signaling pathway in rats. European Journal of Pharmacology, 771, 84–92. https://doi.org/10.1016/j.ejphar.2015.12.021
67. Timar, B., Popescu, S., Timar, R., Baderca, F., Duica, B., Vlad, M. M., Levai, C. M., Bălinişteanu, B., & Simu, M. A. (2016). The usefulness of quantifying intraepidermal nerve fibers density in the diagnostic of diabetic peripheral neuropathy: A cross-sectional study. Diabetology & Metabolic Syndrome, 8, Article 31. https://doi.org/10.1186/s13098-016-0145-x
68. Tiwari, V., Kuhad, A., & Chopra, K. (2011). Emblica officinalis corrects functional, biochemical and molecular deficits in experimental diabetic neuropathy by targeting the oxido-nitrosative stress mediated inflammatory cascade. Phytotherapy Research, 25(10), 1527–1536. https://doi.org/10.1002/ptr.3452
69. Tomlinson, D. R., & Gardiner, N. J. (2008). Glucose neurotoxicity. Nature Reviews Neuroscience, 9(1), 36–45. https://doi.org/10.1038/nrn2294
70. Umapathi, T., Tan, W. L., Loke, S. C., Soon, P. C., Tavintharan, S., & Chan, Y. H. (2007). Intraepidermal nerve fiber density as a marker of early diabetic neuropathy. Muscle & Nerve, 35(5), 591–598. https://doi.org/10.1002/mus.20756
71. Vinogradova, A. V., Sysova, M., Smirnova, P. A., Sidorova, M., Turkin, A., Kurilova, E., & Tuchina, O. P. (2023). Enriched environment induces sex-specific changes in the adult neurogenesis, cytokine and miRNA expression in rat hippocampus. Biomedicines, 11(5), Article 1341. https://doi.org/10.3390/biomedicines11051341
72. Wada, R., & Yagihashi, S. (2005). Role of advanced glycation end products and their receptors in development of diabetic neuropathy. Annals of the New York Academy of Sciences, 1043(1), 598–604. https://doi.org/10.1196/annals.1333.069
73. Yang, L., Liang, J., Lam, S. M., Yavuz, A., Shui, G., Ding, M., & Huang, X. (2020). Neuronal lipolysis participates in PUFA-mediated neural function and neurodegeneration. EMBO Reports, 21(10), Article e50214. https://doi.org/10.15252/embr.202050214
74. Yang, X. W., Liu, F. Q., Guo, J. J., Yao, W. J., Li, Q. Q., Liu, T. H., & Xu, L. P. (2015). Antioxidation and anti-inflammatory activity of Tang Bi Kang in rats with diabetic peripheral neuropathy. BMC Complementary and Alternative Medicine, 15, Article 66. https://doi.org/10.1186/s12906-015-0588-2
75. Zhou, J.Y., & Zhou, S.W. (2012). Protection of trigonelline on experimental diabetic peripheral neuropathy. Evidence-Based Complementary and Alternative Medicine, 2012, Article 164219. https://doi.org/10.1155/2012/164219
76. Zhang, W., Jiang, Y., Shang, Z., Zhang, N., Tao, G., Zhang, T., Hu, K., Li, Y. f., Shi, X., Zhang, Y., & et al. (2019). The methodological quality of animal studies: A cross-sectional study based on the SYRCLE’s risk of bias tool. bioRxiv. https://doi.org/10.1101/754226